Annovis Bio (ANVS) is down -25.6%, or -$1.25 to $3.62.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANVS:
- Annovis Bio announces pricing of $21M offering of stock, warrants
- Annovis Bio granted U.S. patent covering buntanetap
- Annovis Bio announces FDA acceptance of protocol for Phase 3 AD study
- Annovis Bio Advances Alzheimer’s and Parkinson’s Drug Trials
- Annovis Bio Appoints William Fricker as Interim CFO